OAN Staff Jenna Lee and Brooke Mallory
6:53 PM – Thursday, April 23, 2026
President Donald Trump announced a deal with Regeneron, a drug manufacturer and biotechnology company, to reduce the cost of its pharmaceutical products, marking a key milestone in the administration’s flagship drug-pricing initiative.
Under the terms of the agreement, the president stated that Regeneron will lower prices for its entire portfolio, including future releases, within the Medicaid system. Additionally, as confirmed via a White House Fact Sheet, the deal includes offering the…




